Novo Nordisk (United States)

1.1k papers and 41.6k indexed citations i.

About

In recent decades, authors affiliated with Novo Nordisk (United States) have published 1.1k papers, which have received a total of 41.6k indexed citations. Scholars at this organization have produced 472 papers in Endocrinology, Diabetes and Metabolism, 324 papers in Molecular Biology and 165 papers in Surgery on the topics of Diabetes Treatment and Management (310 papers), Diabetes Management and Research (252 papers) and Hemophilia Treatment and Research (141 papers). Their work is cited by papers focused on Endocrinology, Diabetes and Metabolism (16.3k citations), Molecular Biology (11.6k citations) and Surgery (7.0k citations). Authors at Novo Nordisk (United States) collaborate with scholars in United States, Denmark and United Kingdom and have published in prestigious journals including Nature, Science and New England Journal of Medicine. Some of Novo Nordisk (United States)'s most productive authors include Feng Xu, Nathan E. Lewis, Brett E. Skolnick, Paula M. Hale, Stephen M. Davis, Stephan A. Mayer, Michael N. Diringer, Thorsten Steiner, Bruce W. Bode and Nikolai C. Brun.

In The Last Decade

Fields of papers published by authors at Novo Nordisk (United States)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Novo Nordisk (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Novo Nordisk (United States) at the time of their publication.

Countries citing scholars working at Novo Nordisk (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Novo Nordisk (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Novo Nordisk (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Novo Nordisk (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Breakdown of academic impact, for scholars at University of South Carolina Beaufort Breakdown of academic impact, for scholars at NOAA Center for Satellite Applications and Research Breakdown of academic impact, for scholars at St. Joseph's Hospital Breakdown of academic impact, for scholars at Quality Enhancement Research Initiative Breakdown of academic impact, for scholars at Wellcome/MRC Institute of Metabolic Science Breakdown of academic impact, for scholars at Population Council Breakdown of academic impact, for scholars at Nagahama Institute of Bio-Science and Technology Breakdown of academic impact, for scholars at Public Policy Institute of California
Rankless by CCL
2025